Kate Burke
Kate is an experienced regulatory professional having worked in the pharmaceutical industry for the past 20 years. With a background in research and development, Kate has been involved in the registration, maintenance and oversight of a broad range of products including new chemical entities, biological medicines and gene therapies. She has extensive experience in developing regulatory strategies and providing regulatory advice to support new product launches, as well as the preparation, review and assessment of regulatory documentation across all stages of the product lifecycle. In addition to her two undergraduate degrees, a BA and BSc (Hons), Kate has a Post Graduate Diploma in Epidemiology and Biostatistics from the University of Melbourne.
JournalNavigating the regulatory terrain down under: trends in Australia for 2024
Australia is the most populous country in Oceania, and ranks 55th globally with its population around 26 million. It also ranks consistently high in other indicators that demonstrate the country’s above-average wealth. Factors such as a skilled workforce, high-quality research infrastructure, government incentives and well developed regulatory and health technology ...